News Daily News Revascularization Decisions in the Elderly Require a Holistic Approach: AHA Caitlin E. Cox November 24, 2025
News Daily News Risk Calculators Miss Many Patients Who Present With First MI Michael O'Riordan November 21, 2025
News Daily News Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges Caitlin E. Cox November 21, 2025
News Daily News High Adolescent BP Tied to Subclinical Disease in Middle Age Michael O'Riordan November 20, 2025
News Daily News Chronic Pain Linked to Increased Risk for Incident Hypertension L.A. McKeown November 20, 2025
News Daily News Online Calculator Allows Young Adults to See How Their 30-Year CV Risk Compares to Peers’ Yael L. Maxwell November 19, 2025
News Industry News SMT’s Hydra TAVR Valve Demonstrates Sustained Safety, Durability, and Hemodynamic Performance at 5 Years November 19, 2025
News Conference News AHA 2025 POLY-HF: Polypill Pays Dividends in Patients With HFrEF Todd Neale November 14, 2025
News Conference News AHA 2025 Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia Michael O'Riordan November 14, 2025
News Daily News Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned Yael L. Maxwell November 13, 2025
News Conference News AHA 2025 Beta-blockers Not Helpful After MI in Patients With Preserved EF Yael L. Maxwell November 12, 2025
News Conference News AHA 2025 Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids Michael O'Riordan November 10, 2025
News Daily News Fish Oil Halves CV Risk in Patients on Dialysis: PISCES Yael L. Maxwell November 10, 2025
News Conference News AHA 2025 DECAF: Daily Coffee, Not Abstinence, Beneficial for AF Patients Michael O'Riordan November 09, 2025
News Conference News AHA 2025 Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN Michael O'Riordan November 08, 2025
News Conference News AHA 2025 Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia Caitlin E. Cox November 08, 2025
News Conference News AHA 2025 Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV Michael O'Riordan November 08, 2025
News Conference News AHA 2025 CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia Todd Neale November 08, 2025
News Conference News VIVA 2025 ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss L.A. McKeown November 07, 2025